Q fever endocarditis

The American Journal of Medicine
M J TobinR Hone

Abstract

Despite a worldwide distribution of Coxiella burnetii, only single cases of Q fever endocarditis have been reported outside Great Britain and Australia. We present 10 patients; five were female, only four had a history of environmental exposure, and the mitral valve was involved as commonly as the aortic stenosis, and three patients had a prosthetic valve. We confirm the importance of hepatic involvement, thrombocytopenia and hypergammaglobulinemia as diagnostic features. Diagnosis was established by finding and elevated complement-fixing antibody to Phase I C. burnetii antigen. Tetracycline, with or without lincomycin or cotrimoxazole, was used in nine patients, and one patient received cotrimoxazole as as the sole antibiotic agent. Optimal duration of therapy is unknown. In one patient, relapse followed when treatment was stopped after 18 months. Valve replacement was necessary in five patients, because of hemodynamic problems. Five patients died, and the means survival is 36 months with a range of five to 66 months. We suggest that Q fever endocarditis is frequently missed, and we recommend clinicians to consider the diagnosis in all cases of culture-negative endocarditis.

Citations

Oct 1, 1996·European Journal of Epidemiology·M ThibonD M Ojcius
Jul 1, 1985·Irish Journal of Medical Science·J BourkeB Maurer
Mar 31, 1999·Irish Journal of Medical Science·B Boyle, R Hone
Jul 13, 2006·The Canadian Journal of Cardiology·Marc W DeyellNanette Alvarez
Jul 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F FenollarD Raoult
Jan 25, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pierre HoupikianDidier Raoult
Nov 5, 1997·The Pediatric Infectious Disease Journal·S al-HajjarC Jäger
Jan 1, 1990·Annals of the New York Academy of Sciences·T Hackstadt
Jan 1, 1990·Annals of the New York Academy of Sciences·D RaoultG Remy
Jan 1, 1990·Annals of the New York Academy of Sciences·T J Marrie
Jan 1, 1990·Annals of the New York Academy of Sciences·M E FrazierO G Baca
Jul 1, 1987·Antimicrobial Agents and Chemotherapy·M R YeamanO G Baca
Jul 1, 1989·Antimicrobial Agents and Chemotherapy·M R YeamanO G Baca
Mar 1, 1991·Antimicrobial Agents and Chemotherapy·P Y LevyD Raoult
Jan 9, 2001·Clinical Microbiology Reviews·P Brouqui, D Raoult
Nov 1, 1994·Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B·J SzarekM A Chishti
Nov 7, 2001·La Revue de médecine interne·C AuzaryC Carbon
Jan 1, 1997·International Journal of Antimicrobial Agents·T J Marrie, D Raoult
Dec 20, 2002·Seminars in Pediatric Infectious Diseases·Bernard La Scola
May 29, 2012·Current Infectious Disease Reports·Arístides de Alarcón
Jul 30, 2004·American Journal of Hematology·Donald M ArnoldIrwin Walker
Jun 23, 2009·Annals of the New York Academy of Sciences·Xavier CarcopinoAndreas Stein
May 1, 1991·European Journal of Epidemiology·D Raoult
Mar 3, 1988·The New England Journal of Medicine·L S TompkinsM L Cohen
Nov 16, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anne StrailyChristopher D Paddock
Jan 1, 1997·Scandinavian Journal of Infectious Diseases·Y Siegman-IgraI Shalit
Jul 1, 1993·Clinical Microbiology Reviews·L G Reimer
Jun 1, 1983·Microbiological Reviews·O G Baca, D Paretsky
Sep 1, 1993·Antimicrobial Agents and Chemotherapy·D Raoult
Jul 3, 1998·Journal of Clinical Microbiology·P E FournierD Raoult
Sep 1, 1985·Infection and Immunity·J E SamuelL P Mallavia
Oct 9, 1999·Clinical Microbiology Reviews·M Maurin, D Raoult
Oct 1, 1987·Experimental and Molecular Pathology·B H Wen, S R Yu
May 12, 1986·The Medical Journal of Australia·K King, J L Harkness
Apr 1, 1986·The Journal of Pediatrics·D LauferM Longson
May 1, 1987·The American Journal of the Medical Sciences·S M AustinJ E Johnson
Feb 13, 2004·Mayo Clinic Proceedings·Apoor S GamiNaser M Ammash

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.